In a pioneering step that combines space exploration and the development of diabetic patients, Bergel Holding, in cooperation with Axium Space, the company specialized in human space flights, announced the initial results of its scientific research “Sweet Ride”, which was conducted on the International Space Station during the AX-4 mission. This achievement represents a qualitative progress for the UAE, where the study demonstrated the possibility of using daily diabetes tools, on which millions of patients depend on the Earth, to provide accurate and comprehensive monitoring of diabetes in the space environment, and this research opens the door for enabling future astronauts with diabetes, as well as creating new solutions in the field of health care, linking
source
